Insiders Calliditas Therapeutics AB Nasdaq

Equities

CALT

US13124Q1067

Market Closed - Nasdaq Other stock markets 02:00:01 01/06/2024 am IST			5-day change	1st Jan Change
39.99 ^USD	+3.95%		+78.37%	+55.34%

31/05	Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39	MT
31/05	Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Calliditas Therapeutics Announces Executive Changes	07/01	CI
Calliditas Announces Additions to the Management Team, Effective 1 January 2024	01/12	CI
Calliditas Therapeutics' Nomination Committee Composition for the Agm 2024	23/23/23	CI
Calliditas Therapeutics AB Announces Board Changes	30/23/30	CI
Calliditas Therapeutics nomination committee composition for the AGM 2023	24/22/24	AQ
Calliditas Therapeutics' nomination committee composition for the AGM 2023	21/22/21	AQ
Calliditas Therapeutics AB Announces Nomination Committee Composition for the Agm 2023	21/22/21	CI
Calliditas Therapeutics AB Announces Executive Appointments	11/22/11	CI
Calliditas Therapeutics AB Announces Board Changes	19/22/19	CI
Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2022 - Form 6-K	02/21/02	PU
Calliditas Therapeutics? Nomination Committee for the AGM 2022	02/21/02	CI
Calliditas Therapeutics' nomination committee for the AGM 2022	02/21/02	AQ
Calliditas Therapeutics AB Promotes Andrew Udell to President, North America	03/21/03	CI
Calliditas Therapeutics AB Announces Executive Appointments	08/21/08	CI
Calliditas Therapeutics : rsquo; nomination committee for the AGM 2	24/20/24	PU
Calliditas Therapeutics : nomination committee for the AGM 2021	30/20/30	AQ
Calliditas Therapeutics' : nomination committee for the AGM 2021	27/20/27	AQ
Calliditas Therapeutics AB Appoints Jonathan Schur as Group General Counsel	25/20/25	CI
Calliditas Therapeutics AB Announces Executive Changes	24/20/24	CI
Calliditas Therapeutics AB Elects Molly Henderson as Member of the Board of Directors	25/20/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Calliditas Therapeutics AB Nasdaq

Equities

CALT

US13124Q1067

Insiders

Filters